Generation of a long acting GCSF
Rationale: Current therapies require daily injections of GCSF to treat patients with neutropenia and response to treatment is often unpredictable as GCSF is rapidly cleared. A number of approaches to reducing GCSF clearance have been tried mainly through conjugation with another moiety. The technolo...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Sheffield
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.682311 |